The Protein Myth: Our Obsession With Protein and How It Is Killing US

Houston Methodist

G. Davis

Primer on Diabetes Management

Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

S. Inzucchi

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Physicians Committee for Responsible Medicine

T. J. Key

Medications for Weight Loss: The New Satiety Hormones

Scripps Health

K. Fujioka

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

ASPC 2019 Congress on CVD Prevention

R. DeFronzo

Advancing Type 2 Diabetes Care with Omnipod® 5

Omnipod®

V. Shah, D. Kruger, T. Ly

Current Trends in Obesity Pharmacotherapy: Is the Wait (Weight) Over?

University of Louisville

S. S. Krishnasamy

Optimizing Omnipod® 5 for Better Patient Outcomes (featuring Jennife…

Omnipod®

J. Okemah

Do Triglycerides Cause Heart Disease?

National Lipid Association

I. Goldberg

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

Robert Busch

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

Juan Frias

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

University of Colorado Department of Medicine

R. Johnson

Mind over diabetes: a psychologist’s take on the freedom of Omnipod®…

Omnipod®

M. Heyman

MAFLD: What Is It?

Houston Methodist

D. Victor

Labs to Check on Semaglutide or Tirzepatide

Susan Brian

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

Obesity and Heart Health: Weighing the Facts

The North American Thrombosis Forum (NATF)

K. D. Palmer Emrich

Could GLP-1's be a 'Game Changer' For Weight Loss? Can it be a Safer…

Ken Fujioka

Type 2 Diabetes and Omnipod® 5--Unveiling SECURE T2D

Omnipod®

F. Pasquel

Tirzepatide Updates

Diana Isaacs